The Psychedelic Boom Could be Bigger than Cannabis

The psychedelics boom may be even more profitable than cannabis. Granted, such drugs have been written off for years. But that may not be the case for much longer.  With many like LSD, MDMA, and psilocybin showing promise for treating a range of mental and health conditions, including obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating … Continue reading The Psychedelic Boom Could be Bigger than Cannabis

Aurora Cannabis Rockets on CBD deal to enter the U.S. market

Aurora Cannabis is rocketing this morning on news it struck a deal to enter the U.S. cannabis market after buying CBD company, Reliva.  “It’s immediate access into the world’s largest cannabinoid market,” Aurora Executive Chairman and interim CEO Michael Singer, as quoted by CNBC. “I think the Reliva acquisition is a responsible strategic entry into the … Continue reading Aurora Cannabis Rockets on CBD deal to enter the U.S. market

Telehealth Boom Could Create $175 Billion Opportunity by 2026

With the coronavirus making its rounds, telemedicine is under big demand. All as government and health officials advise against face to face meetings.  It’s becoming so popular Global Market Insights estimates the market could be worth $175 billion by 2026. Markets and Markets estimates telehealth could grow from $25.4 billion in 2020 to more than … Continue reading Telehealth Boom Could Create $175 Billion Opportunity by 2026

Moderna (MRNA) Advances to Next Stage of Vaccine Testing

We may be nearing a coronavirus vaccine. Just yesterday, Moderna (MRNA) announced it submitted an Investigational New Drug (IND) application to the US FDA for its mRNA candidate to “evaluate mRNA-1273 in Phase 2 and late-stage studies if supported by safety data from the Phase 1 study led by the National Institute of Allergy and … Continue reading Moderna (MRNA) Advances to Next Stage of Vaccine Testing

IBM Beats Estimates, But Forced to Pull Full-Year Guidance

Shares of IBM slipped in afterhours trading. Not only did it report a pullback in first quarter revenue, in pulled its annual forecast. “Looking at the first quarter, through February we were tracking roughly in-line with our expectations,” said Chief Financial Officer James Kavanaugh as quoted by MarketWatch. “As we got into March, the health … Continue reading IBM Beats Estimates, But Forced to Pull Full-Year Guidance

Three Top Ways Investors are Protecting their Portfolios

On September 1, 2019, the U.S. will be “putting a small additional tariff of 10% on the remaining 300 Billion Dollars of goods and products coming from China into our country,” tweeted President Donald Trump.  “We look forward to continuing our positive dialogue with China on a comprehensive Trade Deal, and feel that the future between our … Continue reading Three Top Ways Investors are Protecting their Portfolios